Related Experiment Video
Updated: May 29, 2026
13:04
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan1, Jermaine I Coward, Robert C Bast
1Ovarian Cancer Action Research Centre, Imperial College London Hammersmith Campus, Du Cane Road, London W12 0NN, UK.
Nature Reviews. Cancer
|September 24, 2011
Summary
Researchers have made significant progress in understanding ovarian cancer biology. Nine key recommendations are proposed to improve treatment outcomes for women diagnosed with this malignancy.
Area of Science:
- Oncology
- Cellular Biology
- Molecular Biology
Background:
- Ovarian cancer encompasses a group of human malignancies with complex cellular and molecular characteristics.
- Recent scientific advancements have deepened the understanding of these underlying biological mechanisms.
Framework:
- A consensus meeting convened international researchers to discuss strategies for improving patient outcomes.
- The focus was on translating biological insights into actionable clinical strategies.
Implementation:
- Nine major recommendations were formulated based on the expert discussions.
- These recommendations aim to guide future research and clinical practice.
Implications:
- The proposed actions are intended to enhance the effectiveness of ovarian cancer treatments.
- Improved outcomes for women with ovarian cancer are the primary goal of these recommendations.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...